Amsterdam, J., Brunswick, D. & Mendels, J. (1980) The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels.
American Journal of Psychiatry, 137, 653–62.
Bayliss, P. F. C., Dewsbury, A. R., Donald, J. F., Harcup, J. W., Mayer, M., Million, R., Molla, A. L., Murphy, J. E., Plant, B. & Shaoul, E. (1974) A double-blind controlled trial of ‘vivalan’ (viloxazine hydrochloride) and imipramine hydrochloride in the treatment of depression in general practice.
Journal of International Medical Research, 2 (4), 260–4.
Bereen, F. J. (1973) A new potential antidepressive.
Lancet, i, 379–80.
Kiloh, L. G. & Garside, R. F. (1963) The independence of neurotic depression and endogenous depression.
British Journal of Psychiatry, 109, 451–63.
Lasagna, L. (1971) Decision processes in establishing the efficacy and safety of psychoactive agents. In Principles and Problems in Establishing the Efficacy of Psychotropic Agents (eds. J. Levine, B. C. Schiele, and L. Bouthilet). Public Health Service Publication No. 2138.
Overall, J. E., Hollister, L. E., Pokorny, A. D., Casey, J. F. & Katz, G. (1962) Drug therapy in depressions. Controlled evaluation of imipramine, isocarboxazid, dextroamphetamine, amobarbital, and placebo.
Clinical Pharmacology and Therapeutics, 3, 16.
Pichot, P., Guelfi, J. & Dreyfus, J. F. (1975) A controlled multicentre therapeutic trial of viloxazine (vivalan).
Journal of International Medical Research, 3, Suppl 3, 80–6, 100.
Tsegos, I. K. & Ekdawi, M. Y. (1974) Double-blind controlled comparison of imipramine and viloxazine in depression.
Current Medical Research and Opinion, 2, 455–60.
Uhlenhuth, E. G. & Park, L. C. (1964) The influence of medication (imipramine) and doctor in relieving depressed psychoneurotic outpatients.
Journal of Psychiatric Research, 2, 101–22.